Subscribe   RSS Contact Us

Pitts Calls Higher Drug Approval Rate a Sign of Regulatory Progress

Aug. 24, 2015 – Although some may call the FDA to task for approving more new drugs than they have ... read more

CHC and CCC Launching Regulatory Compliance University for Agencies, Publishers

Aug. 19, 2015 – The Coalition for Healthcare Communication (CHC) is partnering with the Center for Communication Compliance (CCC) to ... read more

Kamp on Presidential Politics: They Matter to Medical Marketers

Aug. 17, 2015 – In an Aug. 11 column posted on the PharmaLive website, Coalition for Healthcare Communication Executive Director ... read more

Amarin Federal Court Decision: FDA Off-Label Marketing Rules Violate the First Amendment By John Kamp

Aug. 10, 2015 – Late last week the U.S. District Court for the Southern District of New York granted Amarin ... read more

FDA Will Study How Market Claims, Efficacy Info Affect Consumers in DTC Drug Print Ads

July 29, 2015 – The FDA’s Office of Prescription Drug Promotion (OPDP) recently announced that it plans to conduct a ... read more

Congressional Briefing: Medical Information Communication Is Important Patient Issue

July 28, 2015 – Physicians and their patients need access to truthful and non-misleading data about available treatments, including off-label ... read more

CME Update: CMS Revises Guidance and Industry Ups Spending

July 20, 2015 – Two recent developments in the continuing medical education (CME) arena – a revision to CME guidance ... read more

Kamp: 21st Century Cures Act and Amarin Case Developments Are Signs of Progress

July 13, 2015 –Two events last week – the House approval of the 21st Century Cures legislation and arguments in ... read more

House Approves 21st Century Cures Act, Bill Now Heads to the Senate

July 10, 2015 — The House of Representatives today passed H.R. 6, also known as the 21st Century Cures Act, ... read more

21st Century Cures Legislation Garners House Majority Support

July 1, 2015 – The 21st Century Cures Act, which was unanimously approved by the House Energy and Commerce Committee ... read more

Google SEM Changes Affect Drug Black Box Reminder-like, Redirecting Ads

June 29, 2015 – Two changes to search engine marketing (SEM) recently announced by Google could soon alter how pharmaceutical ... read more

Physicians Say CHC-backed H.R. 293 Would Remedy “Burdensome” Sunshine Act Reporting

June 15, 2015 – More than 100 physician organizations have written to Rep. Michael Burgess (R-TX) to express their strong ... read more

Author of “Pharmaphobia” Says Conflict-of-interest Regulations Are Slowing Medical Progress

June 8, 2015 – In his new book, “Pharmaphobia: How the Conflict of Interest Myth Undermines American Medical Innovation,” Tom ... read more

Revised Guidance on Use of Brief Summary in Print DTC Ads: Full PI Is Not Needed or “Recommended”

Feb. 9, 2015 – In a revised draft guidance document released Feb. 6, the FDA is updating a 2004 version ... read more

Previous Next

PhRMA: Engaging the Consumer Is Key to Healthcare Success

Aug. 12, 2013 — An increasing focus on the healthcare consumer’s needs and preferences may play a role in future industry product development priorities. According to a recent health survey commissioned the Pharmaceutical Research and Manufacturers of America (PhRMA), 86 percent of Americans believe that developing cures for more forms of cancer should be one of the top national health priorities, followed by effective treatment for heart disease (78 percent) and more intensive medical care for seniors (76 percent).

The PhRMA survey, “From Hope to Cures: PhRMA’s First Annual Health Survey,” was conducted by Hart Research Associates and “explores Americans’ attitudes on personal health and medical concerns.” This survey and the FDA’s ongoing initiatives to engage patients in dialogues about particular conditions and therapies – as well as clinical trials – demonstrate the growing role that consumers play in their own healthcare.

“Clearly, the PhRMA research demonstrates once again that patient communication and engagement is key to better health outcomes,” said Coalition for Healthcare Communication Executive Director John Kamp. “Indeed, public policy makers must begin to understand that medical communication by medicine companies plays a major part in the safe and effective use of medications.”

John J. Castellani, president and CEO of PhRMA, said in a statement that a patient-centric dialogue “is crucial to improving health outcomes,” and that the survey findings will help “inform efforts to address major health challenges such as chronic disease, improved prevention and wellness activities and enhanced patient adherence to prescribed therapies.”

Other consumer concerns listed in the survey findings are obesity, diet and weight management. For additional coverage of the survey, go to Medivo’s BTP Insights at: 

http://beyondthepill.medivo.com/2013/08/seeking-to-improve-outcomes-phrma-surveys-americans-to-find-out-about-leading-health-concerns/?utm_source=hs_email&utm_medium=email&utm_content=9950489&_hsenc=p2ANqtz–ddm8mrsUlFCgR_jo6roaueLdlegIjltGOKmM84cnP-Vt-l45g6tY66t9mbxYSfxYgOUJf18yJ5U5xg8uhSf2DqQ85Cg&_hsmi=9950489